Efficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis.
This systematic review and meta-analysis pooled randomized controlled trials of GLP-1 receptor agonists in adults receiving antipsychotic treatment for overweight or metabolic dysregulation.
Why it matters
Antipsychotic-associated weight and metabolic changes can be clinically important, and these pooled trial results suggest GLP-1RAs may improve weight-related and glycemic measures in this population.